Who Paid My Doc
Gian Rossi
Neurology with Special Qualifications in Child Neurology Lakeland, FL Doctor of Osteopathy
NPI 1497142178 CMS profile 7232058
1324 Lakeland Hills Blvd Ste A, Lakeland, FL 33805
General payments
$52,282
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Gian Rossi of Lakeland, FL is reported in the CMS Open Payments database as having received $52,282 across 158 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 92nd percentile of Neurology with Special Qualifications in Child Neurology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $34,429 | 70 | |
| 2024 | General | $16,173 | 45 | |
| 2023 | General | $518 | 20 | |
| 2022 | General | $282 | 9 | |
| 2021 | General | $737 | 9 | |
| 2020 | General | $128 | 4 | |
| 2019 | General | $15 | 1 |
Beside peers
- Gian Rossi
- Neurology with Special Qualifications in Child Neurology median
- Middle half of Neurology with Special Qualifications in Child Neurology
- National median
In program year 2025, general payments to Gian Rossi were reported at $34,429. Among 1,228 Neurology with Special Qualifications in Child Neurology profiles paid that year, the median was $276 and the middle half received between $87 and $1,522.
Show as a table
| Year | Gian Rossi | Neurology with Special Qualifications in Child Neurology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $15 | $262 | $68–$1,313 | $163 |
| 2020 | $128 | $188 | $46–$1,222 | $114 |
| 2021 | $737 | $183 | $45–$1,356 | $132 |
| 2022 | $282 | $229 | $72–$1,177 | $149 |
| 2023 | $518 | $269 | $93–$1,195 | $160 |
| 2024 | $16,173 | $300 | $98–$1,428 | $164 |
| 2025 | $34,429 | $276 | $87–$1,522 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
158 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Neurology with Special Qualifications in Child Neurology in Florida
Paul Winner
Neurology with Special Qualifications in Child Neurology · West Palm Beach, FL
Omer Abdul Hamid
Neurology with Special Qualifications in Child Neurology · Orlando, FL
Natalie Gillson
Neurology with Special Qualifications in Child Neurology · Fort Myers, FL
Trevor Resnick
Neurology with Special Qualifications in Child Neurology · Miami, FL
Migvis Monduy
Neurology with Special Qualifications in Child Neurology · Miami, FL
Elza Vasconcellos
Neurology with Special Qualifications in Child Neurology · Miami, FL
Related records
Neurology with Special Qualifications in Child Neurology in Florida
Practitioners in the same specialty and state, ranked by reported value.
All Neurology with Special Qualifications in Child Neurology
Everyone recorded under this specialty, nationwide.
Doctors in Florida
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.